Combined metabolic activators to treat mitochondrial dysfunction Mitochondrial dysfunction is a common feature of many human diseases and is emerging as a therapeutic target. Systems biology and multiomics approaches have revealed that Carnitine metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney disease treatment ScienceDirect The mechanism by which long chain fatty acids enter the mitochondria. Download Scientific Diagram Carnitine Shuttle an overview ScienceDirect Topics